Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Precision Telemed vs PrideRx

Two GLP-1 deals, scored on the same six factors. Precision Telemed lands a Value Score of 89, PrideRx a 72. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Precision Telemed

#10 · Grade A · Great Deal

Est. first month

$149/mo

Save ~89% vs brand-name
Get this deal Full Precision Telemed review →
VS

PrideRx

#204 · Grade C · Watch List

Est. first month

From $149/mo (starting dose, plus a separate fee, brand-name)

Get this deal Full PrideRx review →

The verdict

Better value: Precision Telemed

Precision Telemed takes it on Value Score, 89 to 72 an est. $149/mo first month, with no teaser step-up baked in. PrideRx isn't out of it: Shoppers who want brand-name-only GLP-1s (Zepbound, Wegovy Pill, Foundayo) fulfilled by LillyDirect and NovoCare.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealPrecision TelemedPrideRx
Value Score89 (A)72 (C)
Est. first month$149/moFrom $149/mo (starting dose, plus a separate fee, brand-name)
Save vs brand-name~89%
Semaglutide$149/moFrom $149/mo (starting dose, plus a separate fee, brand-name)
Tirzepatide$199/moFrom $299/mo (2.5 mg dose, plus a separate fee, brand-name)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

88
Lowest Real Price
82
Precision Telemed: 88. PrideRx: 82.
86
No Teaser-Rate Bait
64
Precision Telemed: 86. PrideRx: 64.
98
Nationwide Availability
45
Precision Telemed: 98. PrideRx: 45.
92
Both Molecules
98
Precision Telemed: 92. PrideRx: 98.
84
Easy Cancellation
54
Precision Telemed: 84. PrideRx: 54.
82
Reputation
73
Precision Telemed: 82. PrideRx: 73.

Precision Telemed

A LegitScript-certified, all-50-state program with an honest $149 / $199 flat price on both molecules.

Why it's a deal

  • LegitScript-certified and available in all 50 states
  • Flat $149 semaglutide / $199 tirzepatide — no step-up
  • Both molecules priced up front

The fine print

  • Not the rock-bottom sticker — sub-$100 sema tiers exist
  • No brand-name or oral option

PrideRx

PrideRx is an LGBTQ+-friendly telehealth platform offering brand-name-only GLP-1 weight loss — Zepbound (tirzepatide) from $299/mo, Wegovy Pill (oral semaglutide) from $149/mo, and Foundayo (orforglipron)…

Why it's a deal

  • All three brand-name GLP-1 options on one platform — Zepbound injection, Wegovy Pill, and Foundayo — no compounded substitutes
  • Medication ships from and is billed by LillyDirect or NovoCare; PrideRx never handles or re-sells the drug
  • Transparent published per-dose pricing with on-page verification dates
  • $99/mo membership includes doctor visits and prescription management; 24-hour prescription review

The fine print

  • $99/mo membership on top of medication cost — all-in runs $248–$548/mo depending on drug and dose
  • Legal entity and prescribing medical group are not named on the site
  • No LegitScript certification visible
  • State availability is not published — telehealth consult rules vary by state
Get the Precision Telemed deal Get the PrideRx deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Precision Telemed is ranked on the Precision Telemed alternatives board, and the same list for the other side is on alternatives to PrideRx.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.